Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D06NTB
|
|||
| Former ID |
DNC004168
|
|||
| Drug Name |
3-(4-Methyl-piperidin-1-ylmethyl)-1H-indole
|
|||
| Synonyms |
21000-95-3; BRN 0191400; CHEMBL57478; 3-(4-Methyl-piperidin-1-ylmethyl)-1H-indole; INDOLE, 3-((4-METHYLPIPERIDINO)METHYL)-; 3-((4-Methylpiperidino)methyl)indole; 3-[(4-methylpiperidin-1-yl)methyl]-1H-indole; AC1L1JK7; AC1Q2R9P; Oprea1_731728; Oprea1_382776; AURORA 16336; SCHEMBL13504100; CTK8H5660; DTXSID30175210; MolPort-001-815-823; ZINC142608; BDBM50050469; STK617550; 3-[(4-methylpiperidyl)methyl]indole; AKOS002266584; MCULE-4620579742; ACM21000953; 3-(4-Methylpiperidinomethyl)-1H-indole; LS-83280; BAS 02946824; ST50190326
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C15H20N2
|
|||
| Canonical SMILES |
CC1CCN(CC1)CC2=CNC3=CC=CC=C32
|
|||
| InChI |
1S/C15H20N2/c1-12-6-8-17(9-7-12)11-13-10-16-15-5-3-2-4-14(13)15/h2-5,10,12,16H,6-9,11H2,1H3
|
|||
| InChIKey |
DGCGMYNLCDVYMB-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 21000-95-3
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dopamine D2 receptor (D2R) | Target Info | Inhibitor | [1] |
| Dopamine D3 receptor (D3R) | Target Info | Inhibitor | [1] | |
| Dopamine D4 receptor (D4R) | Target Info | Inhibitor | [1] | |
| KEGG Pathway | Neuroactive ligand-receptor interaction | |||
| Dopaminergic synapse | ||||
| Rap1 signaling pathway | ||||
| cAMP signaling pathway | ||||
| Gap junction | ||||
| Parkinson's disease | ||||
| Cocaine addiction | ||||
| Alcoholism | ||||
| Panther Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||
| Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | ||||
| Dopamine receptor mediated signaling pathway | ||||
| Nicotine pharmacodynamics pathway | ||||
| Reactome | Dopamine receptors | |||
| G alpha (i) signalling events | ||||
| WikiPathways | Hypothetical Network for Drug Addiction | |||
| Monoamine GPCRs | ||||
| GPCRs, Class A Rhodopsin-like | ||||
| Genes and (Common) Pathways Underlying Drug Addiction | ||||
| GPCR ligand binding | ||||
| GPCR downstream signaling | ||||
| Nicotine Activity on Dopaminergic Neurons | ||||
| GPCRs, Other | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | 3-((4-(4-Chlorophenyl)piperazin-1-yl)-methyl)-1H-pyrrolo-2,3-b-pyridine: an antagonist with high affinity and selectivity for the human dopamine D4... J Med Chem. 1996 May 10;39(10):1941-2. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.